Midazolam por via oral como medicação pré-anestésica em crianças e adolescentes com paralisia cerebral: estudo comparativo das variações do índice bispectral
Oral midazolam as pre-anesthetic medication in children and teenagers with cerebral palsy: a comparative study on the variations of the bispectral index
Verônica Vieira da Costa; Rafael Villela Silva Derré Torres; Érika Carvalho Pires Arci; Renato Ângelo Saraiva
Resumo
Palavras-chave
Abstract
BACKGROUND AND OBJECTIVES: Midazolam is a benzodiazepine with hypnotic action widely used as pre-anesthetic medication in pediatric anesthesia. Children with cerebral palsy (CP) also benefit from the use of midazolam, but its effects on this group of patients, who present several particularities, including changes at the site of action of midazolam, are still unknown. The objective of this study was to evaluate the effects of midazolam, when used as pre-anesthetic medication, on the bispectral index (EEG-BIS) of patients with cerebral palsy. METHODS: Two groups of patients were evaluated: one group with the diagnosis of CP and the other without central and peripheral nervous system disorders. The EEG-BIS was recorded in the room, the day before the surgery, and at the day of the surgery, 40 minutes after the administration of 0.6 mg.kg-1 of oral midazolam. Patients with a history of paradoxal reaction to midazolam as well as patients in the control group who were using other medications were excluded. RESULTS: Seventy-seven patients of both genders, 4 to 18 years old, participated in this study. Differences in EEG-BIS between both groups were not detected. After the use of midazolam EEG-BIS decreased in both groups with a statistically significant difference in each group. Statistically significant intergroup differences were not observed. CONCLUSIONS: Midazolam, used as pre-anesthetic medication, at a dose of 0.6 mg.kg-1, reduced basal EEG-BIS without characterizing hypnosis and without statistically significant differences between the study groups.
References
Kain ZN, Caldwell-Andrews AA, Krivutza DM. Trends in the practice of parenteral presence during induction of anesthesia and the use of preoperative sedative premedication in the United States, 1995-2002: results of a follow up national survey. Anesth Analg. 2004;98:1252-1259.
Kain ZN, Mayes LC, Bell C. Premedication in the United States: a status report. Anesth Analg. 1997;84:427-432.
McCann M, Kain ZN. The management of preoperative anxiety in children: an update. Anesth Analg. 2001;93:98-105.
Bax MC, Goldestein M, Rosenbaum P. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol. 2005;47:571-576.
Maranhão MVM. Anestesia e paralisia cerebral. Rev Bras Anestesiol. 2005;55:680-702.
Wongprasartsuk P, Stevens J. Cerebral palsy and anaesthesia. Paediatr Anaesth. 2002;12:296-303.
Campos da Paz Jr A, Burnett SW, Nomura AM. Neuromuscular Affections in Children. Mercer´s Orthopaedics Surgery. 1996:399-474.
Duff FH, Iyer VG, Surwillo WW. Sistemas de Registro. Eletroencefalografia Clínica e Mapeamento Cerebral Topográfico: Tecnologia e Prática. 1999:77-83.
Costa VV, Torres RVSD, Arci ECP. Comparação dos valores do índice bispectral em pacientes com paralisia cerebral em estado de vigília. Rev Bras Anestesiol. 2007;57:382-390.
Johansen JW, Sebel PN. Development and clinical application of electroencephalografic bispectrum monitoring. Anesthesiology. 2000;93:1336-1344.
Brosius KK, Bannister CF. Effect of oral midazolam premedication on the awakening concentration of sevoflurane, recovery times and bispectral índex in children. Paediatr Anaesth. 2001;11:585-590.
Costa VV, Saraiva RA. Ação do óxido nitroso no sistema nervoso central: estudo eletrofisiológico como agente único e como agente coadjuvante. Rev Bras Anestesiol. 2002;52:255-271.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email